Clinical Trial Update: Prospective Investigation of Dynamics of ABL Mutations in Imatinib Failed CML Patients Treated With Nilotinib

View source ↗

Summary

This clinical trial investigates how ABL mutations change over time in patients with chronic myeloid leukemia who failed imatinib and are treated with nilotinib…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (Tasigna) (nilotinib)

Snippet

Sponsor: Seoul St. Mary's Hospital | Conditions: Chronic Myeloid Leukemia | Status: UNKNOWN